Literature DB >> 7762064

Evidence for increased nitric oxide production after liver transplantation in humans.

I Ioannidis1, A Hellinger, C Dehmlow, U Rauen, J Erhard, F W Eigler, H De Groot.   

Abstract

To evaluate the role of in vivo-produced nitric oxide (NO) after orthotopic liver transplantation, nitrate, a stable end product of spontaneous NO conversion in blood, was assayed in plasma samples of 32 patients. In 31 patients, nitrate increased from 36 +/- 2 microM to 137 +/- 8 microM within the first 6 postoperative days. In 11 out of 12 patients with an uneventful early postoperative course, nitrate increased from 33 +/- 2 microM to 70 +/- 8 microM, and returned to baseline levels within 2-3 days. In the remaining 20 patients with episodes of rejection and/or infection, the nitrate peak was augmented and prolonged. Ten patients suffering from these events in the later postoperative course showed a second nitrate elevation. In 31 patients, effective plasma levels of cyclosporine were reached 4-5 days after OLT. The patient without significant elevation in plasma nitrate had effective levels already at day 1. After liver resection or coronary bypass grafting, the median nitrate level remained at 21 microM (range 15-36 microM; healthy persons: median 24 microM, range 18-32 microM). After kidney transplantation nitrate was elevated in the early postoperative course. Thus, NO formation appears to be increased after solid organ transplantation, but not after other surgeries. After OLT, the increase appears to occur (a) in response to rejection and/or infection, and (b) 4-6 days after surgery in the absence of overt complications. In the latter case, NO might be involved in subclinical rejection and its production is possibly dependent upon the effectiveness of the immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762064

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Nitric oxide level profile in human liver transplantation.

Authors:  Stefania Battista; Giulio Mengozzi; Fabrizio Bar; Elisabetta Cerutti; Cristina Pollet; Mauro Torchio; Fiorella Biasi; Guido Cavalli; Mauro Salizzoni; Giuseppe Poli; Gianpaolo Molino
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.

Authors:  M L Kielar; S C Sicher; J G Penfield; D R Jeyarajah; C Y Lu
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

Review 3.  Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?

Authors:  Florence Herr; Melanie Brunel; Nathalie Roders; Antoine Durrbach
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

4.  Nitric oxide metabolites in cystic fibrosis lung disease.

Authors:  H Grasemann; I Ioannidis; R P Tomkiewicz; H de Groot; B K Rubin; F Ratjen
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

5.  Macrophages in solid organ transplantation.

Authors:  Xinguo Jiang; Wen Tian; Yon K Sung; Jin Qian; Mark R Nicolls
Journal:  Vasc Cell       Date:  2014-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.